What is tinnitus?
- Usually a symptom of an underlying hearing loss.
- A bothersome ringing, buzzing, chirping, whistling or other continuous sound perceived in your head.
- An audiological and neurological condition that is tolerable by some but debilitating to others.
- Sounds perceived in your head, but not usually heard by outsiders, that are often successfully managed by trained hearing healthcare professionals.
- One of the most common health conditions experienced in the United States.
- Originating from the latin past participle, tinnīre, meaning: tinkling, jingling or ringing
Common causes of tinnitus
Exposure to loud noise, ear infections, aging, excessive earwax, hypertension, sensory nerve disorders and certain medications.
Activities that can exacerbate tinnitus
Smoking, consuming alcohol or caffeine, excessive amounts of aspirin, antibiotics or other medications.
Over 45 million American suffer from some form of persistent ringing in the ears. The first step in treating your symptoms is identifying what type of tinnitus you are experiencing. Tinnitus can be classified as: auditory, non-auditory, middle ear, cochlear, vestibular, and cervical. The most common type is associated with hearing impairment. It is important to distinguish which type of tinnitus you have so the appropriate treatment can be applied. Frequently, managing the hearing loss will reduce or eliminate the effects of the unwanted ringing, buzzing, clicking or wooshing sounds. If not, other forms of management can be effective.
At Scarlet M. Lauro, Audiology, we effectively treat tinnitus using sound therapy devices. These technologies aim to reduce the irritation caused by the unwanted ringing in your ears. But which technology or treatment plan would work best for you depends on the type of tinnitus you’re experiencing. Schedule an appointment at Dr. Scarlet M. Lauro Audiology today to have your hearing and tinnitus evaluated. A simple, non-invasive evaluation will give you an idea of what it will take to relieve your suffering. There’s no need to live with tinnitus anymore.
Lenire
Soothe tinnitus
Safe and Effective At-Home Tinnitus Treatment Technology
Lenire® is scientifically proven in a ground- breaking controlled trial to significantly reduce tinnitus severity leading to an over improved quality of life.
Is Lenire suitable for you?
Lenire is for adults over the age of 18 with subjective tinnitus. Lenire must be recommended by a trained professional.
Contraindications
Lenire is not suitable if:
- You have a pacemaker, defibrillator or any other active implantable device.*
- You are pregnant.*
- You have epilepsy or any other condition that may result in loss of consciousness.*
- You have any condition that causes impaired sensitivity of the tongue.**
- You have oral cavity inflammation, sores or lesions that may contact the Tonguetip.**
- You have any intermittent or chronic neuralgia in the head and neck area.
- If you have Meniere’s disease.* Lenire use has not been evaluated for Meniere’s disease.
- If you have objective source tinnitus.
- In the presence of oral piercings.
*Unless directed by a physician.
*Unless directed by a physician or dentist.
About Neuromod Devices
Neuromod U.S.A. Inc. is a wholly owned subsidiary of Neuromod Devices Ltd. headquartered in Illinois.
Neuromod specializes in the design and development of neuromodulation technologies to address the clinical needs of underserved patient populations who live with chronic and debilitating conditions.
Neuromod’s tinnitus treatment device, Len ire, is the first non-invasive bimodal neuromodulation device shown to soothe and relieve tinnitus in a controlled large-scale clinical trial. As a result, Leriire is the first treatment device of its kind to be granted De Novo FDA approval.
Frequently Asked Questions
Can I purchase Lenire over the counter?
How Long is Lenire treatment?
Lenire should be used for two 30-minute sessions daily for a treatment timeframe recommended by your tinnitus care professional.
Was Lenire's trial controlled?
A New Approach to Treating Tinnitus
What is the Lenire Device
Lenire comes with three pieces of equipment:

Controller
A lightweight handheld device that controls the time and intensity of the treatment.

Headphones
Audio customized to your hearing and tinnitus plays through Bluetooth Headphones to activate the brain's auditory nerve.

Tonguetip
A proprietary intraoral device that sits comfortably on the tongue that delivers mild and safe pulses to stimulate the tongue.
Real World Patient Stories
"Lenire is a powerhouse of a treatment device for me."
"I think devices like Lenire show that there is hope out there."
"Lenire is a game-changer. It is what I had been waiting for."
Watch patient stories: www.lenire.com/pratient-stories
Customized Lenire Treatment Plans
Your healthcare provider will customize Lenire and provide you with a tailored treatment plan.
Typical Treatment Plan
1
Hearing and Tinnitus Assessment
Visit a Lenire-qualified healthcare
provider and learn if Lenire is the right
treatment for you.
2
Lenire Device Fitting
The Lenire device is customized to
your tinnitus and hearing profile.
3
Home Use
Use Lenire daily as advised by your
healthcare provider.
4
Follow Up 1
Visit your provider to review progress.
5
Home Use
Continue to use Lenire daily as advised by your healthcare provider.
6
Follow Up 2
Visit your provider to review progress
and discuss continued use of Lenire.
Groundbreaking Tinnitus Treatment Clinically Proven in Controlled Trial
In Lenire’s most recent clinical trial, TENT-A3, Lenireproven to be safe, effective and recommended highpatients who used Lenire as instructed.
Typical Treatment Plan
91.5%
of 220 real world Lenire patients clinically significant improvements tinnitus 5
71%
83%
Zero
serious adverse side effects relateLenire were reported, validating thsafety of the device.
One
bimodal neuromodulation tinnitustreatment device granted approvathe FDA following a controlled clirtrial- Lenire.
References
- Dercy et al. BMJ Open 2017.7e018465
- Conlon et al., JMIR Res Protoc 2019.9(9):e13176
- Conlon et al., Sci Translational Medicine. 12, eabb2830 (202)
- Boects, Michael, et al. Nature communications 151(2024) 6806.
- McMahan, Emily E, and Hubert H. Lim. medRxiv (2024): 2024-08